Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14330628 | 0.85 | HDAC4 (0.41) | GPR35HDAC3HDAC4HDAC1HDAC6 | |
| SCHEMBL21501418 | 0.75 | HDAC4 (0.38) | GPR35HDAC3HDAC4HDAC1HDAC6 | |
| SCHEMBL25306722 | 0.70 | DAO (0.44) | HDAC3HDAC4HDAC1HDAC6NPSR1 | |
| SCHEMBL7039134 | 0.70 | ALDH1A1 (0.50) | HDAC3HDAC4HDAC1HDAC6NPSR1 | |
| SCHEMBL21501143 | 0.68 | CES2 (0.51) | HDAC3HDAC4HDAC1HDAC6NPSR1 | |
| SCHEMBL21501401 | 0.68 | MAPT (0.43) | GPR35NPSR1ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL3310480 | 0.68 | ALDH1A1 (0.45) | GPR35NPSR1L3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3310482 | 0.68 | ALDH1A1 (0.45) | GPR35NPSR1L3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3310472 | 0.68 | ALDH1A1 (0.45) | GPR35NPSR1L3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL15038070 | 0.67 | HDAC4 (0.41) | HDAC3HDAC4HDAC1HDAC6NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190322676-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARM INC (US) | 2019-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322676-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | UGCG, MAN2B1, GBA1 | GPR35 2618/4885HDAC3 382/4885HDAC4 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.